Actually, the HIF-1α/NLRP3 pathway has been recognized as a potential molecular target for treating ischemic stroke and traumatic brain injury because it regulates microglia activation and inflammatory cytokines release in the inflammatory cascade after brain injury [17, 47, 48]. Here, NLRP3 is linked to ischemic stroke.